Bleselumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Bleselumab
Monoclonal antibody
Type ?
Source Human
Target CD40
Clinical data
Synonyms ASKP1240
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
Formula C6412H9906N1690O2018S38
Molar mass 144.2 g/mol

Bleselumab (INN[1]) (ASKP1240) is a human monoclonal antibody designed for the prevention of organ transplant rejection.

This drug was developed by Kyowa Kirin Pharmaceutical Development Inc.[2]

References[edit]